V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010762 | 250010969 | 0 | 100 | Palliative (P) | 2017-09-25 | 2017-10-21 | IPM | N | N | 250032147 | CARBOPLATIN |
| 250010763 | 250007963 | 1.72 | 85 | Adjuvant (A) | 2014-11-11 | 2014-11-11 | IPM | N | N | 250032161 | PEMETREXED |
| 250010765 | 250007964 | 1.59 | 81.4 | Disease modification (D) | 2015-07-04 | 2015-07-20 | Busulfan Oral | 2 | N | 250032165 | IPM |
| 250010766 | 250007965 | null | null | Palliative (P) | 2015-10-26 | 2015-11-22 | AML17 TRIAL | N | null | 250032166 | FLAG + IDARUBICIN |
| 250010767 | 250007966 | 0 | 71 | Disease modification (D) | 2017-05-17 | 2017-05-17 | IPM | 02 | N | 250032169 | CARBOPLATIN + PACLITAXEL |
| 250010768 | 250007967 | 1.72 | 78 | Disease modification (D) | 2017-11-12 | 2017-11-14 | Cytarabine High Dose | N | N | 250032177 | CARBOPLATIN + PACLITAXEL |
| 250010769 | 250010971 | null | null | Disease modification (D) | 2016-02-18 | 2016-03-15 | Rituximab | N | N | 250032187 | AFLIBERCEPT + FU + IRINOTECAN |
| 250010770 | 250012147 | 1.73 | 61.8 | Disease modification (D) | 2016-02-26 | 2016-02-26 | Azacitidine | N | N | 250032189 | IPM |
| 250010771 | 250012147 | null | 64.5 | Palliative (P) | 2017-07-21 | 2017-07-21 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 250032189 | IPM |
| 250010772 | 250007970 | 1.78 | 0 | Curative (C) | 2015-05-13 | 2015-08-05 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 250032220 | PEMETREXED |
| 250010773 | 250007971 | 1.72 | 66.8 | Palliative (P) | 2014-03-24 | 2014-04-16 | GemCarbo Days 1+8 | 02 | N | 250032225 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE |
| 250010774 | 250007973 | 1.55 | 66 | Curative (C) | 2017-06-20 | 2017-06-20 | VEPEMB | 02 | N | 250032238 | GEMCARBO |
| 250010775 | 250010973 | 1.74 | 74 | Curative (C) | 2014-11-20 | 2015-04-09 | Bortezomib + Cyclophos + Dex | 2 | N | 250032240 | NILOTINIB |
| 250010776 | 250007975 | 1.86 | 0 | Curative (C) | 2017-05-04 | 2017-05-12 | Azacitidine | 02 | N | 250032242 | IPM |
| 250010777 | 250007976 | 1.67 | 61.8 | Palliative (P) | 2017-03-02 | 2017-03-10 | COMMAND trial | null | N | 250032243 | CISPLATIN |
| 250010778 | 250007977 | 1.62 | 66.5 | Palliative (P) | 2016-02-15 | 2016-02-15 | BUSULFAN + FLUDARABINE | N | N | 250032248 | RADIUM 223 |
| 250010779 | 250007978 | null | null | Disease modification (D) | 2015-01-21 | 2015-01-21 | Azacitidine | N | N | 250032252 | OXALIPLATIN + MDG |
| 250010780 | 250007979 | 1.61 | 57.8 | Palliative (P) | 2018-01-15 | 2018-02-13 | Busulfan Oral | N | N | 250032256 | CYTARABINE HIGH DOSE |
| 250010781 | 250007980 | null | 86 | Curative (C) | 2016-08-17 | 2016-08-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 250032257 | NOT MATCHED |
| 250010782 | 250007981 | null | null | Palliative (P) | 2017-01-21 | 2017-02-15 | GemCarbo Days 1+8 | N | N | 250032258 | GEMCARBO |
| 250010783 | 250007982 | null | 87 | null | 2014-11-05 | 2014-11-05 | Azacitidine | N | N | 250032261 | FEC + DOCETAXEL |
| 250010784 | 250007983 | 0 | 49.8 | Palliative (P) | 2013-10-20 | 2013-10-20 | Busulfan Oral | N | N | 250032262 | ENZALUTAMIDE |
| 250010786 | 250007986 | 1.78 | 96 | Palliative (P) | 2013-08-08 | 2014-06-02 | FLAG + Idarubicin | null | N | 250032275 | IRINOTECAN + MDG |
| 250010787 | 250007987 | null | 124.3 | Curative (C) | 2017-10-10 | 2018-03-24 | GEMCARBO | null | N | 250032282 | CISPLATIN + GEMCITABINE |
| 250010788 | 250007988 | 1.66 | 52.6 | Disease modification (D) | 2017-07-15 | 2017-07-16 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250032287 | CISPLATIN |
| 250010789 | 250007988 | 0 | 81.4 | Curative (C) | 2014-01-24 | 2014-02-13 | COMMAND trial | 02 | N | 250032287 | PEMETREXED |
| 250010790 | 250007989 | null | 96 | Disease modification (D) | 2017-08-02 | 2017-08-15 | Triple Intrathecal | N | N | 250032301 | GEMCARBO |
| 250010791 | 250007990 | 1.76 | 0 | Palliative (P) | null | 2018-08-23 | ANAGRELIDE | null | N | 250032303 | COPP + DACARBAZINE |
| 250010792 | 250007990 | 1.81 | 74.6 | Curative (C) | 2016-03-01 | 2016-03-02 | Abiraterone | 02 | N | 250032303 | CHOP R |
| 250010793 | 250007991 | 1.7 | 57 | Palliative (P) | 2016-05-26 | 2016-05-26 | Azacitidine | 01 | N | 250032316 | GEMCITABINE |
| 250010794 | 250007992 | 1.65 | 83 | Curative (C) | 2016-04-21 | 2016-05-10 | GEMCARBO | 02 | N | 250032318 | CISPLATIN |
| 250010795 | 250007994 | 1.75 | 73 | Palliative (P) | 2015-09-19 | 2015-09-27 | GemCarbo Days 1+8 | Y | N | 250032323 | FEC + DOCETAXEL |
| 250010796 | 250007995 | null | null | Curative (C) | null | 2017-09-10 | CHOP R - 21 days | null | N | 250032330 | CARBOPLATIN + PACLITAXEL |
| 250010797 | 250007996 | 1.78 | 149 | Palliative (P) | 2017-11-08 | 2017-11-08 | EVEROLIMUS | N | N | 250032333 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250010798 | 250007996 | 1.68 | 83.2 | Curative (C) | 2015-05-28 | 2016-05-22 | CARBOPLATIN + GEMCITABINE | N | N | 250032333 | GEMCITABINE |
| 250010799 | 250007997 | null | 0 | Palliative (P) | 2018-03-06 | 2018-03-31 | Brentuximab | null | N | 250032346 | AZACITIDINE |
| 250010800 | 250007998 | null | null | Curative (C) | 2018-03-17 | 2018-03-23 | GemCarbo Days 1+8 | N | null | 250032349 | COMMAND TRIAL |
| 250010801 | 250008000 | 1.66 | 79.4 | Curative (C) | 2016-04-20 | 2016-05-10 | Cytarabine Low Dose | N | N | 250032350 | NOT MATCHED |
| 250010802 | 250010982 | 1.74 | 72 | Disease modification (D) | 2014-01-12 | 2014-01-19 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 250032350 | CARBOPLATIN + DOXORUBICIN |
| 250010803 | 250008001 | null | 62.4 | Curative (C) | 2017-01-25 | 2017-01-25 | Rituximab (Maintenance) | 02 | N | 250032357 | BORTEZOMIB |
| 250010804 | 250008002 | 1.56 | 124.3 | Palliative (P) | 2017-09-27 | 2017-09-27 | DOCETAXEL + GEMCITABINE | N | N | 250032365 | NOT MATCHED |
| 250010805 | 250008003 | 1.78 | 66.6 | Curative (C) | 2016-11-30 | 2016-11-30 | COMMAND trial | N | N | 250032375 | CISPLATIN + VINORELBINE |
| 250010806 | 250008004 | 1.76 | 72 | Palliative (P) | 2014-03-04 | 2014-08-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250032375 | CARBOPLATIN + VINORELBINE |
| 250010807 | 250008004 | null | null | null | 2014-04-17 | 2014-07-19 | Rituximab | N | null | 250032375 | OXALIPLATIN + RALTITREXED |
| 250010808 | 250008005 | 1.7 | 66.5 | Disease modification (D) | 2013-11-01 | 2013-11-01 | GemCarbo Days 1+8 | 02 | N | 250032395 | ESHAP R |
| 250010809 | 250008006 | 1.73 | 98.7 | Palliative (P) | 2014-12-31 | 2015-01-06 | FLUOROURACIL + IRINOTECAN | N | N | 250032396 | IPM |
| 250010810 | 250008008 | null | -1 | Curative (C) | 2016-01-21 | 2016-01-21 | Paclitaxel 7 day | Y | N | 250032406 | GEMCARBO |
| 250010811 | 250008008 | 1.69 | 57.8 | null | 2017-05-09 | 2017-05-29 | COMMAND trial | N | N | 250032406 | GEMCARBO |
| 250010812 | 250008008 | null | 52.6 | Curative (C) | 2015-09-23 | 2015-10-01 | Azacitidine | N | N | 250032406 | NOT MATCHED |
| 250010813 | 250008008 | 1.61 | 58.3 | Disease modification (D) | 2016-10-28 | 2016-11-09 | Busulfan Oral | N | N | 250032406 | PERTUZUMAB + TRASTUZUMAB |